Statins and Endocrine Treatment
Showing 1 - 25 of 2,168
Spinal Cord Injuries, Osteoporosis, Metabolic Syndrome Trial in Miami, Toronto (Rosuvastatin Calcium, Placebo Oral Tablet,
Active, not recruiting
- Spinal Cord Injuries
- +2 more
- Rosuvastatin Calcium
- +4 more
-
Miami, Florida
- +1 more
Oct 19, 2021
Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)
Not yet recruiting
- Metastatic Breast Cancer
-
Al Madīnah, AL, Saudi ArabiaAsmaa Imam Ahmed
Oct 8, 2023
Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)
Completed
- Intracerebral Hemorrhage
- Atorvastatin
- +2 more
-
Szczecin, West Pomeranian, PolandPomeranian Medical University
Oct 16, 2023
Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine
Not yet recruiting
- Breast Cancer
- Standard of care administration of Endocrine therapy
- Dose-frequency escalation administration of Endocrine therapy
- (no location specified)
Feb 22, 2023
"Iron Overload and Endocrinological Diseases"
Recruiting
- Iron Overload
- +4 more
-
Modena, ItalyUnit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
Nov 13, 2023
Breast Cancer Trial in Bani Suwayf, Fayoum (Atorvastatin 80mg, )
Recruiting
- Breast Cancer
- Atorvastatin 80mg
- placebo
-
Banī Suwayf, Egypt
- +1 more
Oct 31, 2022
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,
Not yet recruiting
- Breast Cancer
- TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
- Placebo capsules, Letrozole, Anastrozole, Tamoxifen
-
Beijing, Beijing, China
- +1 more
Mar 10, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,
Recruiting
- Metastatic Cancer
- +2 more
- 18F-fluorofuranylnorprogesterone
- +2 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 10, 2023
Hormonal Contributors to COVID-19 Infection (COV-ENDO)
Active, not recruiting
- COVID-19 Pandemic
- Endocrine System Diseases
- blood testing
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Mar 6, 2023
Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)
Active, not recruiting
- Atheroscleroses, Coronary
- Rosuvastatin and Ezetimibe
- Rosuvastatin
-
Seoul, Korea, Republic of
- +1 more
Oct 1, 2022
Induced Alopecia Among Postmenopausal and Premenopausal Female
Recruiting
- Breast Carcinoma
- Electronic Health Record Review
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)
Not yet recruiting
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Atorvastatin
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 27, 2023
Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and
Not yet recruiting
- Breast Cancer
- Advanced Breast Cancer
- Everolimus 10 mg
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 14, 2023
Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)
Recruiting
- Breast Cancer
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Breast Cancer Trial in New York (core needle biopsy, blood draw)
Recruiting
- Breast Cancer
- core needle biopsy
- blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023
Stage I Breast Cancer Trial in United States (Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane),
Recruiting
- Stage I Breast Cancer
- Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
- Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
-
Birmingham, Alabama
- +512 more
Feb 1, 2023
CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent
Not yet recruiting
- Breast Cancer
- +3 more
- Different treatment regimens following progression on CDK4/6 inhibitors.
- (no location specified)
Sep 5, 2023
Breast Cancer Trial in Lund (Letrozole, Letrozole and atorvastatin, Fulvestrant)
Recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Lund, SwedenLund University Hospital, Department of Oncology
Sep 1, 2020
ST-segment Elevation Myocardial Infarction Trial in Damanhur (Rosuvastatin 20 mg ,40 mg, Atorvastatin 40mg,80mg)
Completed
- ST-segment Elevation Myocardial Infarction
- Rosuvastatin 20 mg ,40 mg
- Atorvastatin 40mg,80mg
-
Damanhūr, EgyptDamanhour University
Jun 6, 2023
Maternal Endocrine System and Metabolic Diseases and Offspring
Not yet recruiting
- Thyroid Dysfunction
- Diabetes Mellitus
- (no location specified)
Jul 17, 2023
Breast Cancer Trial in Madison (drug, device, other)
Not yet recruiting
- Breast Cancer
- 18F-fluorofuranylnorprogesterone
- +4 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 11, 2023